Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic adenocarcinoma: a pilot study of the clinical trial EudraCT 2016-004298-41

BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) with gemcitabine, after cytoreductive surgery, may reduce the tumor progression of pancreatic cancer through the reduction of the neoplastic volume and the subpopulation of residual pancreatic cancer stem cells, improving the survival of...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Gastrointest Oncol
Главные авторы: Padilla-Valverde, David, García-Santos, Esther, Sanchez, Susana, Manzanares, Carmen, Rodriguez, Marta, González, Lucia, Ambrós, Alfonso, Cano, Juana M., Serrano, Leticia, Bodoque, Raquel, Vergara, Teresa, Martin, Jesus
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2021
Предметы:
Original Article on Pancreas Cancer
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100727/
https://ncbi.nlm.nih.gov/pubmed/33968428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-238
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы